Investing.com - Financial Markets Worldwide

Hans Biomed Corp (042520)

KOSDAQ
Currency in KRW
23,000
-2,300(-9.09%)
Closed·
042520 Scorecard
Full Analysis
Net income is expected to grow this year
Trading near 52-week High
042520 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
23,00027,600
52 wk Range
6,18027,600
Key Statistics
Edit
Bid/Ask
23,000.00 / 23,050.00
Prev. Close
25,300
Open
24,750
Day's Range
23,000-27,600
52 wk Range
6,180-27,600
Volume
797.05K
Average Volume (3m)
421.56K
1-Year Change
166.7%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
042520 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 17
Analysts anticipate sales growth in the current year
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Hans Biomed Corp Company Profile

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. The company was founded in 1990 and is headquartered in Seoul, South Korea.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
277
Market
South Korea

Compare 042520 to Peers and Sector

Metrics to compare
042520
Peers
Sector
Relationship
P/E Ratio
−33.0x−5.4x−0.7x
PEG Ratio
16.20−0.090.00
Price/Book
5.3x1.9x2.6x
Price / LTM Sales
3.8x13.3x3.4x
Upside (Analyst Target)
-0.0%37.6%
Fair Value Upside
Unlock26.1%5.3%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-250.00 / --
Revenue / Forecast
22.03B / --
EPS Revisions
a
a
Unlock
Last 90 days

042520 Income Statement

People Also Watch

Doosan Heavy Ind. & Const.
80,200
034020
-4.18%
L&C Bio
48,850
290650
-7.31%
Tomocube
42,700.00
475960
-5.43%
SK Hynix Inc
465,500
000660
+2.87%
Palantir
178.22
PLTR
+0.06%

FAQ

What Stock Exchange Does Hans Biomed Trade On?

Hans Biomed is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Hans Biomed?

The stock symbol for Hans Biomed is "042520."

What Is the Hans Biomed Market Cap?

As of today, Hans Biomed market cap is 328.57B.

What Is Hans Biomed's Earnings Per Share (TTM)?

The Hans Biomed EPS (TTM) is -768.17.

When Is the Next Hans Biomed Earnings Date?

Hans Biomed will release its next earnings report on 17 Dec 2025.

From a Technical Analysis Perspective, Is 042520 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Hans Biomed Stock Split?

Hans Biomed has split 0 times.

How Many Employees Does Hans Biomed Have?

Hans Biomed has 277 employees.

What is the current trading status of Hans Biomed (042520)?

As of 17 Oct 2025, Hans Biomed (042520) is trading at a price of 23,000, with a previous close of 25,300.00. The stock has fluctuated within a day range of 23,000 to 27,600, while its 52-week range spans from 6,180 to 27,600.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.